Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
Year: 2011
Type: article
Source: Alzheimer s & Dementia
Authors: Reisa A. Sperling, Clifford R. Jack, Sandra E. Black, Matthew P. Frosch, Steven M. Greenberg, Bradley T. Hyman, Philip Scheltens, Maria C. Carrillo, William Thies, Martin M. Bednar, Ronald S. Black, H. Robert Brashear, Michael Grundman, Eric R. Siemers, Howard H. Feldman, Rachel J. Schindler
Institutions: Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital, Mayo Clinic, Sunnybrook Health Science Centre, University of Toronto, Amsterdam UMC Location Vrije Universiteit Amsterdam, Alzheimer's Association, Pfizer (United States), Janssen Alzheimer Immunotherapy Research & Development (United States), Eli Lilly (United States), Yale University, Bristol-Myers Squibb (United States)
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institute on Aging
OpenAlex ID: W2108216694